APSR2026-308

 
Late-Breaking
Submitted
Oral Presentation
AO28-001
 
 
https://storage.unitedwebnetwork.com/files/1285/1217006-46903-APSR2026-308_439583.pptx
Format: PPTX Only
 
Format: PDF Only
09. Asthma
9

No more than 15 authors can be listed.
Please ensure the authors are listed in the right order.
If there are multiple affiliations, please use the "+" button next to "Select Country/Region" to add additional affiliation fields.

Tony Chun Hei LEI * The Chinese University of Hong Kong (CUHK) Department of Paediatrics, Faculty of Medicine Hong Kong Hong Kong The Chinese University of Hong Kong (CUHK) Hong Kong Hub of Obstetric and Paediatric Excellence Hong Kong Hong Kong The Chinese University of Hong Kong (CUHK) Laboratory for Paediatric Respiratory Research, Li Ka Shing Institute of Health Sciences Hong Kong Hong Kong
Tao ZHOU - Shenzhen Baoan Women's and Children's Hospital Shenzhen Baoan Women's and Children's Hospital Shenzhen China
Shuiwen CHEN - Shenzhen Baoan Women's and Children's Hospital Shenzhen Baoan Women's and Children's Hospital Shenzhen China
Kate Ching-Ching CHAN - The Chinese University of Hong Kong (CUHK) Department of Paediatrics, Faculty of Medicine Hong Kong Hong Kong The Chinese University of Hong Kong (CUHK) Hong Kong Hub of Obstetric and Paediatric Excellence Hong Kong Hong Kong
Agnes Sze Yin LEUNG - The Chinese University of Hong Kong (CUHK) Department of Paediatrics, Faculty of Medicine Hong Kong Hong Kong
Maggie Haitian WANG - The Chinese University of Hong Kong (CUHK) JC School of Public Health and Primary Care Hong Kong Hong Kong
Andreas MÖLLER - The Chinese University of Hong Kong (CUHK) JC STEM Lab, Department of Otorhinolaryngology Hong Kong Hong Kong
Jiang CHENG - The Chinese University of Hong Kong (Shenzhen) Department of Biomedical Engineering, School of Medicine Shenzhen China
Renee Wan Yi CHAN - The Chinese University of Hong Kong (CUHK) Department of Paediatrics, Faculty of Medicine Hong Kong Hong Kong The Chinese University of Hong Kong (CUHK) Hong Kong Hub of Obstetric and Paediatric Excellence Hong Kong Hong Kong The Chinese University of Hong Kong (CUHK) Laboratory for Paediatric Respiratory Research, Li Ka Shing Institute of Health Sciences Hong Kong Hong Kong The Chinese University of Hong Kong (CUHK) 8 SH Ho Research Centre for Infectious Diseases, Faculty of Medicine Hong Kong Hong Kong
 
 
 
 
 
 
Presenting Author Details
Tony Chun Hei
LEI
chlei@link.cuhk.edu.hk
+85253998553
Under 30
 
Original Research
Nasal extracellular vesicle proteomics uncovers promising biomarkers for atopic asthma diagnosis in school-age children
Maximum 25 words
Abstract Content
Wheezing affects approximately 20% preschool children with 25–30% progress to persistent asthma. Diagnostic accuracy in children (<6 years) is constrained by reliance on symptoms and therapeutic trials and limitations of standard clinical tools (e.g., API and FeNO) leading to over- and under-diagnosis rates of 25-35%. Stage-specific biomarkers are needed to predict asthma progression and enable precision treatment. Extracellular vesicles (EVs) are promising for early detection in many diseases, outperforming free proteins, yet paediatric nasal fluid EV profiles in atopic asthma remain underexplored. This proof-of-concept study examines nasal EV proteomics in school-age children with confirmed diagnoses.
The PAECISE cohort recruited 133 children aged 6–12 years. In the discovery cohort, nasal EVs were isolated from 8 atopic asthmatics, 8 non-asthmatic controls, and 4 non-asthmatic allergic children via size-exclusion chromatography and ultrafiltration. Proteomics was performed using LC–MS/MS (nanoElute UHPLC–timsTOF Pro 2, DIA). Differential proteins were identified using |log₂ fold change| > 1 and p < 0.05, or high ROC AUC. Logistic regression model shortlisted a biomarker panel, validated by leave-one-out cross-validation (LOOCV). PPI analysis, GSEA, Pearson correlation, and ANOVA were used to ensure biological specificity.
Atopic asthma was associated with 48 upregulated and 39 downregulated nasal EV proteins. A three-protein panel (NAT1, CCDC6, and S100A6) achieved an AUC of 0.938 for distinguishing atopic asthma. LOOCV confirmed high alignment with clinical diagnosis, with a 15% overall error rate. CTNS abundance correlated with FEV1% across groups, while CCDC6 and CTNS abundances differed significantly between short-acting β-agonist (SABA) users and non-users among asthmatics.
Nasal EV proteins reflect current atopic asthma status and hold promise for predicting progression. Validation in the expanded PAECISE cohort (~50 subjects) is underway using an ultra-sensitive electrochemiluminescence platform.
 
 
 
 
 
No
No
 
JPG or JPEG or PNG format ONLY
Paediatric asthma, Extracellular vesicles proteins, Mathematical modelling
maximum 3 keywords and no abbreviations, separated by commas
 
282